Literature DB >> 25042093

Pain in hereditary neuropathy with liability to pressure palsy: an association with fibromyalgia syndrome?

Ugur Yilmaz1, Thomas T Bird, Gregory T Carter, Leo H Wang, Michael D Weiss.   

Abstract

INTRODUCTION: This study characterizes the nature of pain in hereditary neuropathy with liability to pressure palsy (HNPP).
METHODS: This retrospective study was performed to assess duration, nature, location, and intensity of pain on initial presentation of subjects with HNPP, including the degree and type of analgesic medication use and electrodiagnostic characteristics. Subjects who met the American College of Rheumatology criteria for fibromyalgia syndrome (FMS) were also identified.
RESULTS: Of 32 HNPP subjects, 24 (75%) had symptoms of pain, and 4 (12%) had pain as an initial symptom. Of subjects who described pain, 9 (28%) reported only musculoskeletal pain, 10 (31%) only neuropathic pain, and 5 (16%) both musculoskeletal and neuropathic pain. All 9 subjects with only musculoskeletal pain met criteria for FMS.
CONCLUSIONS: Neuropathic and musculoskeletal pain occur commonly in HNPP and may be a presenting symptom. Additionally, HNPP with predominantly musculoskeletal pain may meet criteria for FMS and potentially delay the diagnosis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Charcot-Marie-Tooth; chronic pain; fibromyalgia; hereditary neuropathy with liability to pressure palsy; neuropathic pain

Mesh:

Year:  2015        PMID: 25042093     DOI: 10.1002/mus.24331

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Characterisation of pain in people with hereditary neuropathy with liability to pressure palsy.

Authors:  Darren Beales; Robyn Fary; Cameron Little; Shruti Nambiar; Hakon Sveinall; Yen Leng Yee; Brigitte Tampin; Tim Mitchell
Journal:  J Neurol       Date:  2017-10-27       Impact factor: 4.849

Review 2.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

Review 3.  Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019).

Authors:  Erinn C Cameron; Samantha L Hemingway
Journal:  J Cannabis Res       Date:  2020-05-29

Review 4.  Diagnostic confounders of chronic widespread pain: not always fibromyalgia.

Authors:  Winfried Häuser; Serge Perrot; Claudia Sommer; Yoram Shir; Mary-Ann Fitzcharles
Journal:  Pain Rep       Date:  2017-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.